LEO 32731 for the Treatment of Moderate to Severe Psoriasis Vulgaris

NCT02888236 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis Vulgaris

Interventions

DRUG: LEO 32731
DRUG: LEO 32731 Placebo

Sponsor

LEO Pharma